| 000 | 01563 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515150740.0 | ||
| 264 | 0 | _c20090402 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2008.03887.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPelletier, A-L | |
| 245 | 0 | 0 |
_aInfliximab treatment for symptomatic Crohn's disease strictures. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cFeb 2009 |
||
| 300 |
_a279-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aConstriction, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xcomplications |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIleal Diseases _xdrug therapy |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKalisazan, B | |
| 700 | 1 | _aWienckiewicz, J | |
| 700 | 1 | _aBouarioua, N | |
| 700 | 1 | _aSoulé, J-C | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 29 _gno. 3 _gp. 279-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2008.03887.x _zAvailable from publisher's website |
| 999 |
_c18491620 _d18491620 |
||